Accordingly, the expression of ACTN4 in carcinoma tissues was higher than that in adjacent tissues in patients with NSCLC, which was detected by immunohistochemistry (IHC) assay (Figure 4E,F). The gene discussed is ACTN4; the disease is carcinoma.